Sangamo Therapeutics, Inc. (SGMOQ)
0.1475
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Sangamo Therapeutics EPS Diluted (Quarterly) : -0.0796 for March 31, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.0796 |
| December 31, 2025 | -0.1108 |
| September 30, 2025 | -0.1148 |
| June 30, 2025 | -0.0778 |
| March 31, 2025 | -0.1389 |
| December 31, 2024 | -0.1113 |
| September 30, 2024 | 0.0438 |
| June 30, 2024 | -0.1771 |
| March 31, 2024 | -0.2722 |
| December 31, 2023 | -0.3395 |
| September 30, 2023 | -0.5879 |
| June 30, 2023 | -0.6568 |
| March 31, 2023 | 0.1249 |
| December 31, 2022 | -0.3155 |
| September 30, 2022 | -0.3363 |
| June 30, 2022 | -0.2914 |
| March 31, 2022 | -0.3008 |
| December 31, 2021 | -0.2573 |
| September 30, 2021 | -0.328 |
| June 30, 2021 | -0.3276 |
| March 31, 2021 | -0.321 |
| December 31, 2020 | -0.2869 |
| September 30, 2020 | -0.011 |
| June 30, 2020 | -0.2585 |
| March 31, 2020 | -0.3698 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.036 |
| September 30, 2019 | -0.236 |
| June 30, 2019 | -0.2648 |
| March 31, 2019 | -0.4121 |
| December 31, 2018 | -0.1829 |
| September 30, 2018 | -0.1262 |
| June 30, 2018 | -0.17 |
| March 31, 2018 | -0.23 |
| December 31, 2017 | -0.15 |
| September 30, 2017 | -0.15 |
| June 30, 2017 | -0.17 |
| March 31, 2017 | -0.23 |
| December 31, 2016 | -0.14 |
| September 30, 2016 | -0.27 |
| June 30, 2016 | -0.38 |
| March 31, 2016 | -0.23 |
| December 31, 2015 | -0.20 |
| September 30, 2015 | -0.13 |
| June 30, 2015 | -0.17 |
| March 31, 2015 | -0.08 |
| December 31, 2014 | -0.06 |
| September 30, 2014 | -0.11 |
| June 30, 2014 | -0.10 |
| March 31, 2014 | -0.12 |
| December 31, 2013 | -0.13 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
| Vicapsys Life Sciences, Inc. | -0.003 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -31.00M |
| Revenue (Quarterly) | 1.442M |
| Total Expenses (Quarterly) | 32.44M |
| Enterprise Value | 52.85M |
| Gross Profit Margin (Quarterly) | 39.18% |
| Profit Margin (Quarterly) | -2.15K% |
| Earnings Yield | -259.7% |
| Normalized Earnings Yield | -241.90 |